Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans. [electronic resource]
Producer: 20001219Description: 483-91 p. digitalISSN:- 0264-410X
- Antibodies, Viral -- biosynthesis
- Antigens, Viral -- genetics
- Double-Blind Method
- Encephalitis Virus, Japanese -- genetics
- Encephalitis, Japanese -- immunology
- Erythema -- etiology
- Genetic Vectors
- Humans
- Neutralization Tests
- Poxviridae -- genetics
- Safety
- Vaccines, Attenuated -- adverse effects
- Vaccines, Synthetic -- adverse effects
- Vaccinia -- immunology
- Viral Vaccines -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.